Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin + Ergometrine vs Oxytocin Alone for Prevention of Postpartum Hemorrhage in Twin Cesarean Deliveries
ChiCTR2600127079Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Control: Oxytocin + Placebo with Intervention: Oxytocin + Ergometrine (2 arms). Primary endpoint: Incidence of composite outcome of postpartum hemorrhage and related complications within 24 hours postpartum. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
oxytocinergonovine maleate
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ChiCTR2600127079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127079.